Sex Differences in Procedure Selection and Outcomes of Patients Undergoing Mitral Valve Surgery
Background: There is a paucity of data on sex differences in procedure selection and outcomes of patients undergoing mitral valve surgery.
Methods and Results: The National Inpatient Sample database from 2005 to 2008 was searched to identify patients ?30 years of age who underwent mitral valve repair or replacement (ICD-9-CM codes 35.12, 35.23, and 35.24). Women constituted 51.6% of the patients, and they were older, were less affluent, had higher values for the Charlson comorbidity index, and more often presented on an urgent/emergent basis. Women underwent repair less often than men (37.9% versus 55.9%, P < .001) and more often underwent concomitant tricuspid surgery or a Maze procedure. After adjustment for propensity scores, women were more likely to undergo replacement (odds ratio, 1.78; 95% confidence interval, 1.64-1.93; P = .0001), they had longer lengths of stay, and less favorable disposition. Among the patients who underwent mitral valve repair, women had a higher hospital mortality (2.06% versus 1.36%, P = .0328). After adjustment for propensity scores and concomitant procedures, this relationship was no longer statistically significant.
Conclusions: Women are less likely than men to receive mitral valve repair. Although the higher hospital mortality of women presenting for mitral valve surgery was accounted for by their worse preoperative profiles, this sex disparity reflects the current reality in surgical practice and identifies an important area for future improvement in the care of patients with valvular heart disease.
[AHRQ]Agency for Healthcare Research and Quality. 2010. HCUP quality control procedures. Available at: Accessed October 2010 http://www.hcup-us.ahrq.gov/db/quality.jsp'>http://www.hcup-us.ahrq.gov/db/quality.jspnAranki SF, Rizzo RJ, Couper GS 1993. Aortic valve replacement in the elderly. Effect of gender and coronary artery disease on operative mortality. Circulation 88:II17-23.nAvierinos JF, Inamo J, Grigioni F, Gersh B, Shub C, Enriquez-Sarano M. 2008. Sex differences in morphology and outcomes of mitral valve prolapse. Ann Intern Med 149:787-95.nBarnett SD, Ad N. 2009. Surgery for aortic and mitral valve disease in the United States: a trend of change in surgical practice between 1998 and 2005. J Thorac Cardiovasc Surg 137:1422-9.nBearden D, Allman R, McDonald R, Miller S, Pressel S, Petrovitch H. 1994. Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc 42:1143-9.nBlankstein R, Ward RP, Arnsdorf M, Jones B, Lou YB, Pine M. 2005. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern hospitals. Circulation 112:I323-7.nBonow RO, Carabello BA, Chatterjee K, et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e1-142.nBukkapatnam RN, Yeo KK, Li Z, Amsterdam EA. 2010. Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program). Am J Cardiol 105:339-42.nD'Hoore W, Bouckaert A, Tilquin C. 1996. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 49:1429-33.nDeyo RA, Cherkin DC, Ciol MA. 1992. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-9.nDoenst T, Ivanov J, Borger MA, David TE, Brister SJ. 2006. Sex-specific long-term outcomes after combined valve and coronary artery surgery. Ann Thorac Surg 81:1632-6.nDuncan AI, Lin J, Koch CG, Gillinov AM, Xu M, Starr NJ. 2006. The impact of gender on in-hospital mortality and morbidity after isolated aortic valve replacement. Anesth Analg 103:800-8.nGammie JS, Sheng S, Griffith BP 2009. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 87:1431-7; discussion 1437-9.nGrossi EA, Galloway AC, Miller JS 1998. Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated? J Thorac Cardiovasc Surg 115:389-94; discussion 394-6.nIbrahim MF, Paparella D, Ivanov J, Buchanan MR, Brister SJ. 2003. Gender-related differences in morbidity and mortality during combined valve and coronary surgery. J Thorac Cardiovasc Surg 126:959-64.nKoch CG, Khandwala F, Nussmeier N, Blackstone EH. 2003. Gender and outcomes after coronary artery bypass grafting: a propensity-matched comparison. J Thorac Cardiovasc Surg 126:2032-43.nKulik A, Lam BK, Rubens FD 2009. Gender differences in the long-term outcomes after valve replacement surgery. Heart 95:318-26.nPerier P, Deloche A, Chauvaud S 1984. Comparative evaluation of mitral valve repair and replacement with Starr, Björk, and porcine valve prostheses. Circulation 70:I187-92.nSong HK, Grab JD, O'Brien SM, Welke KF, Edwards F, Ungerleider RM. 2008. Gender differences in mortality after mitral valve operation: evidence for higher mortality in perimenopausal women. Ann Thorac Surg 85:2040-4.nTaylor NE, O'Brien S, Edwards FH, Peterson ED, Bridges CR. 2005. Relationship between race and mortality and morbidity after valve replacement surgery. Circulation 111:1305-12.nTribouilloy CM, Enriquez-Sarano M, Schaff HV 1999. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99:400-5.nVaccarino V, Abramson JL, Veledar E, Weintraub WS. 2002. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation 105:1176-81.nVaradarajulu S, Kilgore ML, Wilcox CM, Eloubeidi MA. 2006. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc 64:338-47.nWeitzman S, Cooper L, Chambless L 1997. Gender, racial, and geographic differences in the performance of cardiac diagnostic and therapeutic procedures for hospitalized acute myocardial infarction in four states. Am J Cardiol 79:722-6.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).